Published in Immunology on December 01, 1987
Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med (1985) 11.14
Immunologic functions of Ia-bearing epidermal Langerhans cells. J Immunol (1978) 4.55
Studies on human epidermal Langerhans cells. I. Allo-activating and antigen-presenting capacity. Scand J Immunol (1980) 2.09
Role of antigen-presenting cells in the development and persistence of contact hypersensitivity. J Exp Med (1980) 1.99
The induction of hapten-specific T cell tolerance by using hapten-modified lymphoid cells. I. Characteristics of tolerance induction. J Immunol (1976) 1.68
Induction and regulation of contact hypersensitivity by resident, bone marrow-derived, dendritic epidermal cells: Langerhans cells and Thy-1+ epidermal cells. J Immunol (1986) 1.67
FAILURE OF CELLULAR TRANSFER OF TUBERCULIN SENSITIVITY BETWEEN GUINEA PIGS OF DIFFERENT STRAINS. Nature (1964) 1.25
Enrichment of epidermal Langerhans cells by immunoadsorption to Staphylococcus aureus cells. J Immunol (1983) 1.17
The role of epidermal cells in the induction and suppression of contact sensitivity. J Invest Dermatol (1981) 1.08
Enrichment of epidermal Langerhans cells: studies with a monolayer technique and flow cytometry sorting. J Invest Dermatol (1982) 0.96
Induction and suppression of contact sensitivity to fluorescein isothiocyanate (FITC). J Invest Dermatol (1985) 0.89
Intravenously injected, TNP-derivatized, Langerhans cell-enriched epidermal cells induce contact hypersensitivity in Syrian hamsters. J Invest Dermatol (1985) 0.87
Effect of depletion of epidermal dendritic cells on the induction of contact sensitivity in the guinea-pig. Br J Dermatol (1985) 0.85
Suppression of the cutaneous immune response following topical application of the prostaglandin PGE2. Cell Immunol (1987) 0.82
An antigenic determinant common to lymphocytes and Langerhans cells of the guinea pig. Int Arch Allergy Appl Immunol (1987) 0.81
Influence of route on the induction and persistence of delayed type hypersensitivity to alloantigens. J Dermatol (1985) 0.79
Development and characterization of trinitrophenyl-specific L3T4+ T-cell clones. J Invest Dermatol (1986) 0.78
Isolation of epidermal Langerhans cells. Methods Enzymol (1984) 0.78
Making psychological theory useful for implementing evidence based practice: a consensus approach. Qual Saf Health Care (2005) 12.73
New criteria for improved diagnosis of Bardet-Biedl syndrome: results of a population survey. J Med Genet (1999) 5.92
Immunological phenomena in leprosy and related diseases. Adv Immunol (1971) 5.55
Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: a model for activator:coactivator interactions. Cell (1997) 5.39
Selective depletion of lymphoid tissue by cyclophosphamide. Clin Exp Immunol (1972) 5.29
Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide. Immunology (1972) 5.18
Reduced lymphocyte transformation due to a plasma factor in patients with active syphilis. Lancet (1969) 4.92
Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity. Lancet (1990) 4.01
Barriers to incident reporting in a healthcare system. Qual Saf Health Care (2002) 3.86
Central and peripheral effects of anti-lymphocyte sera. Lancet (1967) 3.76
Erythema nodosum leprosum: a clinical manifestation of the arthus phenomenon. Lancet (1969) 3.67
Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet (2000) 3.63
Reversal of immunological tolerance by cyclophosphamide through inhibition of suppressor cell activity. Nature (1974) 3.38
B-cell suppression of delayed hypersensitivity reactions. Nature (1974) 3.37
Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial. Eur Respir J (2007) 2.78
Further studies on B-lymphocyte suppression in delayed hypersensitivity, indicating a possible mechanism for Jones-Mote hypersensitivity. Immunology (1973) 2.65
Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax (2002) 2.63
The biological activities of soluble lymphocyte products. Clin Exp Immunol (1972) 2.58
Studies on the origin and reactive ability in vivo of peritoneal exudate cells in delayed hypersensitivity. Int Arch Allergy Appl Immunol (1967) 2.51
Human immunodeficiency virus infection in two cohorts of homosexual men: neutralising sera and association of anti-gag antibody with prognosis. Lancet (1987) 2.34
Antibody and HIV-1 gp120 recognition of CD4 undermines the concept of mimicry between antibodies and receptors. Nature (1992) 2.27
Low-cost high-resolution fast spin-echo MR of acoustic schwannoma: an alternative to enhanced conventional spin-echo MR? AJNR Am J Neuroradiol (1996) 2.24
Suppressor cells in normal immunisation as a basic homeostatic phenomenon. Nature (1974) 2.23
Cell-mediated immunity in patients with leprosy. Lancet (1969) 2.21
Allertic complications of meningococcal disease. I. Clinical aspects. Br Med J (1973) 2.20
Complement in acute inflammation. J Pathol (1969) 2.20
Detection of mycobacterial rRNA in sarcoidosis with liquid-phase hybridisation. Lancet (1992) 2.11
A study of the passive cellular transfer of local cutaneous hypersensitivity. I. Passive transfer of delayed hypersensitivity in inbred and outbred guinea-pigs. Int Arch Allergy Appl Immunol (1965) 2.09
An analysis of the effects of some types of anti-lymphocyte sera on contact hypersensitivity and certain models of inflammation. Immunology (1968) 2.07
New antibody in early syphilis. Lancet (1970) 1.97
Cytology of the induction of hypersensitivity. Br Med Bull (1967) 1.95
Evidence for circulating immune complexes in lepromatous leprosy. Lancet (1972) 1.94
Interaction between "sensitized lymphocytes" and antigen in vitro. II. Mitogen-induced release of skin reactive and macrophage migration inhibitory factors. Cell Immunol (1970) 1.93
Immunological basis for depression of cellular immunity and the delayed allergic response in patients with lepromatous leprosy. Lancet (1968) 1.88
Electrophoretic mobility of guinea pig peritoneal exudate cells in hypersensitivity reactions. Int Arch Allergy Appl Immunol (1968) 1.88
Interaction between 'sensitized lymphocytes' and antigen in vitro. I. The release of a skin reactive factor. Immunology (1969) 1.82
Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. Thorax (2005) 1.81
Further advances in the management of malignant teratomas of the testis and other sites. Lancet (1983) 1.80
Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease. Respiration (2011) 1.78
Immunological significance of changes in lymph nodes across the leprosy spectrum. Clin Exp Immunol (1971) 1.76
pH-dependent modulation of relaxivity and luminescence in macrocyclic gadolinium and europium complexes based on reversible intramolecular sulfonamide ligation. J Am Chem Soc (2001) 1.74
Effect of lymphocyte mediators on macrophages in vitro. A correlation of morphological and cytochemical changes. Clin Exp Immunol (1973) 1.73
Studies on the ability of the subcellular fractions of epidermis, painted in vivo with DNFB, to cause contact sensitization in the guinea pig. Int Arch Allergy Appl Immunol (1970) 1.66
The effect of prolonged treatment with antilymphocyte serum on the course of infections with BCG and Leishmania enriettii in the guinea-pig. J Pathol (1971) 1.66
Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur J Immunol (1994) 1.61
Lymphocyte response to antigens. A. Afferent side of sensitization arc. Response of lymphocytes to antigens. Transplantation (1967) 1.58
Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. J Thorac Cardiovasc Surg (1993) 1.57
Granuloma formation in lymph-nodes. J Pathol (1970) 1.54
Bleeding and cupping. Ann R Coll Surg Engl (1983) 1.53
Total synthesis of acetate from CO 2 . V. Determination by mass analysis of the different types of acetate formed from 13 CO 2 by heterotrophic bacteria. J Bacteriol (1972) 1.52
Procedures and the professional: the case of the British NHS. Soc Sci Med (1999) 1.51
Improved cloning efficiency of polymerase chain reaction (PCR) products after proteinase K digestion. Nucleic Acids Res (1991) 1.49
Cell-mediated immunity and lymphocyte transformation in syphilis. Proc R Soc Med (1971) 1.48
Control mechanisms in delayed-type hypersensitivity. Br Med Bull (1976) 1.48
Reactogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines - 1978. Rev Infect Dis (1983) 1.46
Reversal by cyclophosphamide of tolerance in contact sensitization. Tolerance induced by prior feeding with DNCB. Immunology (1975) 1.46
Is ultrasound useful for evaluating paediatric inflammatory neck masses? Clin Otolaryngol (2005) 1.45
Expression of vascular addressins and ICAM-1 by endothelial cells in the spinal cord during chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse. Immunology (1991) 1.44
Surface markers on lymphocytes and cells of the mononuclear phagocyte series in skin sections in leprosy. J Pathol (1978) 1.42
Multiple binding sites for bacterial superantigens on soluble class II MHC molecules. Immunity (1995) 1.41
Effect of cyclophosphamide on immunological control mechanisms. Immunol Rev (1982) 1.40
Depth of a strong jovian jet from a planetary-scale disturbance driven by storms. Nature (2008) 1.40
Preliminary results on the purification of the chemical sensitizing agents in alcyonidium gelatinosum. Proc R Soc Med (1966) 1.39
Denatured muscle grafts for nerve repair. An experimental model of nerve damage in leprosy. J Bone Joint Surg Br (1990) 1.39
Expression of the human calcitonin/CGRP gene in lung and thyroid carcinoma. EMBO J (1985) 1.39
Management of lymphoma patients in a cancer unit: an audit of 15 years' experience in a district general hospital. Clin Oncol (R Coll Radiol) (2001) 1.38
Safety culture assessment in community pharmacy: development, face validity, and feasibility of the Manchester Patient Safety Assessment Framework. Qual Saf Health Care (2005) 1.38
Intrinsic function of a neuronal network - a vertebrate central pattern generator. Brain Res Brain Res Rev (1998) 1.38
Metchnikoff revisited. J R Soc Med (1991) 1.36
Structural analyses of CREB-CBP transcriptional activator-coactivator complexes by NMR spectroscopy: implications for mapping the boundaries of structural domains. J Mol Biol (1999) 1.34
Continuous monitoring of arterial oxygen tension using a catheter-tip polarographic electrode in infants. Pediatrics (1976) 1.34
Ultrastructure of cells present in lymph nodes during the development of contact sensitivity. Int Arch Allergy Appl Immunol (1966) 1.34
Mechanisms of reactions in leprosy. Int J Lepr Other Mycobact Dis (1972) 1.33
Immunological significance of lysosomes with lymphocytes in vivo. Nature (1965) 1.32
Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability. Respir Med (2001) 1.31
Central nervous system metastases of choriocarcinoma. 23 years' experience at Charing Cross Hospital. Cancer (1983) 1.31
Cell-mediated immunological processes in leprosy. Bull World Health Organ (1969) 1.31
Release of skin reactive factor from guinea-pig lymphocytes by mitogens. Nature (1970) 1.30
Basophilic leukocytes in delayed hypersensitivity reactions. J Immunol (1974) 1.29
Luminescence imaging microscopy and lifetime mapping using kinetically stable lanthanide(III) complexes. J Photochem Photobiol B (2000) 1.27
Comparison of mycobacterial granulomas in guinea-pig lymph nodes. J Pathol (1982) 1.25
Epicutaneous induction of hyporeactivity in contact sensitization. Demonstration of suppressor cells induced by contact with 2,4-dinitrothiocyanatebenzene. Immunology (1975) 1.25
A disposable catheter-tip transducer for continuous measurement of blood oxygen tension in vivo. Biomed Eng (1971) 1.25
An experimental model for the investigation of the cellular basis of desensitization in contact sensitivity. Int Arch Allergy Appl Immunol (1965) 1.24
The immunological significance of histological changes in the spleen and liver in mouse malaria. Clin Exp Immunol (1973) 1.23
The relation of immune depression and B-cell stimulation during the development of delayed hypersensitivity to soluble antigens. Immunology (1977) 1.23
The construction, identification and partial characterization of plasmids containing guinea-pig milk protein complementary DNA sequences. Biochem J (1981) 1.21
AIDS and leprosy. Lepr Rev (1988) 1.21
Studies on contact hypersensitivity to chromium compounds. Prog Allergy (1973) 1.21